Month: December 2020
Is Equillium Stock a Buy Right Now?
Many investors are wondering if Equillium Inc. (Nasdaq: EQ) stock is a buy right now. Equillium is a biotechnology company that specializes in products for severe autoimmune and inflammatory disorders. And the biotech industry is certainly a hot one these days, thanks to the recent deployment of millions of COVID-19 vaccines.
Wall Street analysts are bullish on this stock, largely on the strength of clinical trials for its anti-CD6 monoclonal antibody, Itolizumab. Successful trials could lead to strong long-term growth.
In this article, we will take a closer look at Equillium stock. Should investors be optimistic about the future? If so, Equillium …read more […]
Red Light Holland (OTC: TRUFF) To Make Groundbreaking Investment in St. Vincent and the Grenadines’ Plant-Based Wellness and Psychedelics Industry
Red Light Holland’s investment through the expected acquisition of Mera Life Sciences would enable global expansion and create a major scientific research and development division to explore plant-based remedies and treatment clinics in the Caribbean […]